The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s bifurcation lesions market report forecasts the bifurcation lesions market size to grow to $3.18 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Bifurcation Lesions Market Report 2023 – https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

Bifurcation Lesions Market Size Forecast
The global bifurcation lesions market is expected to grow from $2.25 billion in 2022 to $2.4 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bifurcation lesions market size is expected to grow to $3.18 billion in 2027 at a CAGR of 7.2%.

North America held the largest bifurcation lesions market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Bifurcation Lesions Market Driver ­– Increase In Geriatric Population
For instance, according to the United Nations Department of Economic and Social Affairs’ September 2020 report, the population aged 65 and above is projected to rise from 9.3% in 2020 to around 16.0% in 2050. Furthermore, according to October 2021 published factsheet by World Health Organization, there will be 1.4 billion individuals over the age of 60 in the world by 2030, up from 1 billion in 2020. Therefore, the increasing geriatric population will drive the bifurcation lesions market.

Request for A Sample Of The Global Bifurcation Lesions Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

Key Bifurcation Lesions Market Trend – Advancement In Devices Used In Imaging And Procedures
Major companies operating in the market are concentrating their efforts on advancements in existing devices used in imaging and procedures. For instance, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm with a unique bifurcation stenting solution to standardize the treatment of all bifurcation lesions in coronary angioplasties, has a platform featuring the only modular self-aligning stent technology to evenly structure bifurcations. The ABS platform is a unique single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment.

Bifurcation Lesions Market Segment
1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular

Bifurcation Lesions Market Major Players and Strategies
Major players in the bifurcation lesions market are Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics, Medtronic, Cardinal Health, Abbott, Tryton Medical Inc., Advanced Bifurcation Systems, and Cook Medical.

In September 2021, Boston Scientific Corporation, a US-based biomedical/biotechnology engineering firm and manufacturer of medical devices used in interventional medical specialties, acquired Devoro Medical, Inc. for an undisclosed amount. Through this acquisition, Boston Scientific will focus on clot management and commercialization using the WOLF Thrombectomy Platform developed by Devoro Medical. Innovative non-console and lytic-free WOLF technology use finger-like prongs to extract and remove thrombi in the arterial and venous systems to target and quickly trap blood clots. This technology will enhance and broaden its selection of interventional strategies for thromboemboli, including the AngioJet Thrombectomy System and the EkoSonic Endovascular System (EKOS). Devoro Medical, Inc is a US-based developer of a medical device intended to restore blood flow.

The Bifurcation Lesions Global Market Report 2023 covers regional data on bifurcation lesions market size, bifurcation lesions market trends and drivers, opportunities, strategies, and bifurcation lesions market competitor analysis. The countries covered in the bifurcation lesions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Bifurcation lesions refer to a coronary artery constriction that occurs next to or involves the origin of a vital side branch one does not want to lose. It occurs when plaque deposits accumulate, and the artery becomes too small for adequate blood flow to your heart.

View More Reports Related To The Bifurcation Lesions Market –
Biopharmaceutical CMO Global Market Report 2023
Bioprocess Containers Global Market Report 2023
Bipolar Disorder Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: